Tech Company Financing Transactions
Eligo Bioscience Funding Round
Eligo Bioscience , based in Paris, secured $30 million in funding from Sanofi Ventures, Bpifrance and Khosla Ventures.
Transaction Overview
Company Name
Announced On
12/8/2023
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
Proceeds Purpose
The French company is focused on addressing diseases driven by the expression of bacterial genes from the microbiome.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
111 Avenue de France
Paris, 75013
FR
Paris, 75013
FR
Phone
Undisclosed
Website
Email Address
Overview
We have assembled talented scientists in synthetic biology, microbiology and immunology with experienced developers and executives, to translate our platform into impactful products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Xavier Duportet
Chief Medical Officer
Mary Spellman
Chief Operating Officer
Aurélie Grienenberger
Browse more venture capital transactions:
Prev: 12/8/2023: Yogi venture capital transaction
Next: 12/8/2023: Hayden AI venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs